TW360711B - CDNAs of Korean hepatitis C virus and polypeptides encoded thereby - Google Patents

CDNAs of Korean hepatitis C virus and polypeptides encoded thereby

Info

Publication number
TW360711B
TW360711B TW081104456A TW81104456A TW360711B TW 360711 B TW360711 B TW 360711B TW 081104456 A TW081104456 A TW 081104456A TW 81104456 A TW81104456 A TW 81104456A TW 360711 B TW360711 B TW 360711B
Authority
TW
Taiwan
Prior art keywords
virus
polypeptides encoded
cdnas
hepatitis
korean hepatitis
Prior art date
Application number
TW081104456A
Other languages
English (en)
Inventor
Yong-Beom Lee
Young-Woo Park
Kook-Jin Lim
Deog-Young Choi
Hong-Seob So
Chun Hyung Kim
Sung Taek Kim
Original Assignee
Lucky Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucky Ltd filed Critical Lucky Ltd
Application granted granted Critical
Publication of TW360711B publication Critical patent/TW360711B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
TW081104456A 1991-06-10 1992-06-08 CDNAs of Korean hepatitis C virus and polypeptides encoded thereby TW360711B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR910009510 1991-06-10
KR910013601 1991-08-06

Publications (1)

Publication Number Publication Date
TW360711B true TW360711B (en) 1999-06-11

Family

ID=26628634

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081104456A TW360711B (en) 1991-06-10 1992-06-08 CDNAs of Korean hepatitis C virus and polypeptides encoded thereby

Country Status (13)

Country Link
US (1) US6538126B1 (zh)
EP (1) EP0521318A3 (zh)
JP (1) JPH06508024A (zh)
CN (1) CN1073118C (zh)
AT (1) AT405053B (zh)
AU (1) AU659649B2 (zh)
BR (1) BR9206131A (zh)
CA (1) CA2111108A1 (zh)
GB (1) GB2272443B (zh)
MX (1) MX9202783A (zh)
TW (1) TW360711B (zh)
UA (1) UA43310C2 (zh)
WO (1) WO1992022655A1 (zh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
DE69232871T2 (de) 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US5593877A (en) * 1993-03-11 1997-01-14 The Rockefeller University Nucleic acid and recombinant production of vespid venom hyaluronidase
KR100312534B1 (ko) * 1993-04-28 2002-05-13 성재갑 씨(c)형간염및비(b)형간염동시측정면역블롯검정키트및면역블롯검정법
KR100312535B1 (ko) * 1993-04-30 2002-06-20 성재갑 혼합항원을이용한씨(c)형간염바이러스의항체진단방법
EP0759979A4 (en) * 1994-05-10 1999-10-20 Gen Hospital Corp ANTISENSE OLIGONUCLEOTIDES INHIBITION OF HEPATITIS C VIRUS
CA2159044A1 (en) * 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
US5985609A (en) * 1994-11-04 1999-11-16 Mogam Biotechnology Research Institute Process for preparing hepatitis C virus envelope glycoproteins
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5874565A (en) 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
GB9604267D0 (en) * 1996-02-29 1996-05-01 Royal Infirmary Of Edinburgh N Mutation assay
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
JP2002125688A (ja) * 2000-10-30 2002-05-08 Tosoh Corp Ｃ型肝炎ウイルスの高感度検出のためのオリゴヌクレオチドおよび検出法
GB0302113D0 (en) * 2003-01-29 2003-03-05 Medical Res Council Ires
CA2539789A1 (en) * 2003-09-22 2005-03-31 Green Peptide Co., Ltd. Peptide originating in hepatitis c virus
US7943046B2 (en) * 2004-10-01 2011-05-17 Agilent Technologies, Inc Methods and systems for on-column protein delipidation
US7449116B2 (en) * 2004-10-01 2008-11-11 Agilent Technologies, Inc. Methods and systems for protein separation
US7705138B2 (en) 2005-11-11 2010-04-27 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
WO2007084567A2 (en) * 2006-01-17 2007-07-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection and discrimination of hepatitis c virus, human immunodeficiency virus type-1 and hepatitis b virus
JP2008125425A (ja) * 2006-11-20 2008-06-05 Osaka Univ 核酸の増幅反応に用いる繰返し配列結合プライマー及びその利用
EP2019117A1 (en) * 2007-07-27 2009-01-28 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Optimized purification process of recombinant growth factor protein
WO2009081285A2 (en) * 2007-12-17 2009-07-02 Medical Research Council Technology Hepatitis c virus antibodies
JP5645840B2 (ja) 2008-12-02 2014-12-24 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ リン原子修飾核酸の合成方法
JP5998326B2 (ja) 2009-07-06 2016-09-28 ウェイブ ライフ サイエンス リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． 新規核酸プロドラッグおよびその使用方法
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
MX347361B (es) 2011-07-19 2017-04-12 Wave Life Sciences Ltd Metodos para la sintesis de acidos nucleicos funcionalizados.
WO2014010718A1 (ja) 2012-07-13 2014-01-16 株式会社新日本科学 キラル核酸アジュバント
DK2872485T3 (da) 2012-07-13 2021-03-08 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
KR102213609B1 (ko) 2012-07-13 2021-02-08 웨이브 라이프 사이언시스 리미티드 키랄 제어
EP3095460A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
EP3095461A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
WO2015108048A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
SG10201912897UA (en) 2014-01-16 2020-02-27 Wave Life Sciences Ltd Chiral design

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0324789B1 (en) * 1986-10-02 2003-08-20 Massachusetts Institute Of Technology Methods of regulating metabolic stability of proteins
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
HU220204B (hu) * 1987-11-18 2001-11-28 Chiron Corp. HCV polipeptidek és HCV polinukleotidok, ilyen polinukleotidokat tartalmazó vektorok és ezekkel transzformált gazdasejtek, valamint HCV fertőzés kimutatására szolgáló diagnosztikumok és immunvizsgálati készlet
WO1990011089A1 (en) * 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
WO1991004262A1 (en) * 1989-09-15 1991-04-04 National Institute Of Health Of Japan New hcv isolates
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
KR940000755B1 (ko) 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
EP0464287A1 (en) 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
NZ238681A (en) 1990-06-25 1992-03-26 Univ Osaka Res Found Non-a, non-b hepatitis virus particles and their production
EP0468657A3 (en) * 1990-07-09 1992-02-05 Tonen Corporation Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis
KR930702365A (ko) 1990-08-25 1993-09-08 존 더블유. 아담슨 비-a형, 비-b형 간염 바이러스 항원, 진단 방법 및 백신

Also Published As

Publication number Publication date
US6538126B1 (en) 2003-03-25
JPH06508024A (ja) 1994-09-14
AT405053B (de) 1999-05-25
EP0521318A2 (en) 1993-01-07
EP0521318A3 (en) 1993-04-28
WO1992022655A1 (en) 1992-12-23
GB2272443A (en) 1994-05-18
CN1068335A (zh) 1993-01-27
ATA901392A (de) 1998-09-15
GB2272443B (en) 1995-10-25
UA43310C2 (uk) 2001-12-17
CA2111108A1 (en) 1992-12-23
BR9206131A (pt) 1995-05-02
GB9324607D0 (en) 1994-02-23
MX9202783A (es) 1994-05-31
AU1902892A (en) 1993-01-12
CN1073118C (zh) 2001-10-17
AU659649B2 (en) 1995-05-25

Similar Documents

Publication Publication Date Title
TW360711B (en) CDNAs of Korean hepatitis C virus and polypeptides encoded thereby
EP0608261A4 (en) COMPOSITION OF AN IMMUNREACTIVE HEPATITIS C VIRUS POLYPEPTIDE.
CA2110058A1 (en) Hepatitis c virus (hcv) polypeptides
EP0992581A3 (en) Immunodominant human T-cell epitopes of hepatitis C virus
NO905234L (no) Fremgangsmaate til fremstilling av meget sintrerbart lanthankromittpulver.
IT9047580A0 (it) Procedimento di trattamento di polveri inorganiche.
NO901338L (no) Fremgangsmaate til sammenfoeyning av elementer, ved fremstilling av termostrukturelle kompositt materialdeler.
NO891226L (no) Fremgangsmaate til fremstilling av fotoherdede belegg.
NO163332C (no) Fremgangsmaate til fremstilling av faste, frittstroemmende hoeyaktivitetspolymeriserings-katalysator-komponenter.
NO901430L (no) Fremgangsmaate til fremstilling av 4(3h)-pteridioner, og medikamenter inneholdende slike.
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
EP0071640A4 (en) NOT-A, NOT-B HEPATITISVIRUS.
NO895067D0 (no) Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose.
NZ238833A (en) Equine herpesvirus-4 gh or gc polypeptides, nucleic acids encoding them and vaccines therefrom
EP0518313A3 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
DE68919617T2 (de) Aminoteil enthaltende Halogenmethyl-1,3,5-Triazine.
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
NO873120L (no) Fremgangsmaate til fremstilling av interferongamma.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO893835L (no) Sic-pulver, fremgangsmaate for fremstilling derav samt anvendelse av pulveret.
NO900219D0 (no) Dihydroksybenzofenon-oksim, samt fremgangsmaate for fremstilling av slike oksimer.
EP0637631A3 (de) Hoch effiziente Expression eines Polypeptids, das eine modifizierte preS1-Region des grossen Hepatitis B-Virus-Antigens enthält.
NO901454L (no) Fremgangsmaate til fremstilling av n-metyl-3,4-dimetoksyfenyletylamin.
FI102835B1 (fi) FSME-viruksen läntisen alatyypin peptidejä ja polypeptidejä ja niitä sisältäviä diagnostisia aineita
Bird The Gold Scene